ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      17,071.60
      0.40%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.225
      -0.39%
      Bitcoin
      63,976.44
      -3.67%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adma Biologics Inc (ADMA)

      7. Adma Biologics Inc (ADMA) News

      ADMA

      Adma Biologics (ADMA)

      Adma Biologics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMA
      DateTimeSourceHeadlineSymbolCompany
      03/11/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
      03/11/202412:19PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
      03/11/20247:00AMGlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
      03/08/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      03/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
      03/05/20247:00AMGlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
      03/04/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      02/28/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      02/28/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      02/28/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      02/28/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      02/28/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      02/28/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      02/28/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
      02/28/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
      02/28/20244:10PMGlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
      02/28/20244:05PMGlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
      02/27/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      02/21/20244:05PMGlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
      02/21/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
      02/21/20247:00AMGlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
      02/14/202411:50AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
      01/08/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
      01/08/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
      01/08/20247:00AMGlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
      01/05/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
      12/18/20234:05PMGlobeNewswire Inc.ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementNASDAQ:ADMAAdma Biologics Inc
      12/12/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
      12/12/20237:00AMGlobeNewswire Inc.ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderNASDAQ:ADMAAdma Biologics Inc
      11/16/20234:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
       Showing the most relevant articles for your search:NASDAQ:ADMA